Endo Pharmaceuticals (A): From LBO to … Harvard Case Solution & Analysis

Endo Pharmaceuticals was founded in 1997 as a leveraged buyout discharge from DuPont Merck. In 1999, he must decide whether to do an IPO or a merger with a smaller company. "Hide
by Richard G. Hamermesh, Brian J. Delacey Source: Harvard Business School 21 pages. Publication Date: January 30, 2006. Prod. #: 806064-PDF-ENG

Endo Pharmaceuticals (A): From LBO to … Case Solution Other Similar Case Solutions like

Endo Pharmaceuticals (A): From LBO to …

Share This